Effect of L-carnitine on myocardial injury in children undergoing open heart surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202010570607420

Enrollment

Registered

2020-10-29

Start date

2020-07-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiology

Interventions

Lcarnitine

placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: children undergoing cardiac surgery for correction of congenital heart disease

Exclusion criteria

Exclusion criteria: children with infective endocarditis, children with heart failure, children with metabolic disease, children with renal or hepatic disease.

Design outcomes

Primary

Measure	Time frame
effect of L-carnitine on troponin I levels	—

Secondary

Measure	Time frame
effect of L-carnitine on CK-MB, caspase-3, malodialdehyde	—

Countries

Egypt

Contacts

Public ContactMohamed Elkashlan

Assistant professor of anesthesiology

mohamedkashlan@yahoo.com+20122337746

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026